Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

193 Press Releases
DateTitleCompany
06 Apr 16 Positive Efficacy And Tolerability Study Of Repatha® (evolocumab) In Statin-Intolerant Patients Published In Journal of the American Medical Association Amgen,
Published by
PharmiWeb.com
16 Mar 16 Amgen Wins Patent Case On Repatha® (Evolocumab) Amgen,
Published by
PR Newswire
07 Mar 16 Amgen Announces 2016 Second Quarter Dividend Amgen ,
Published by
PharmiWeb.com
12 Feb 16 New Drug Treatment Kyprolis® ? (carfilzomib) for Relapsed Multiple Myeloma Launches in the UK Amgen,
Published by
PR Newswire
10 Feb 16 Amgen To Present At The Leerink Partners 5th Annual Global Healthcare Conference Amgen ,
Published by
PharmiWeb.com
27 Jan 16 Vectibix® (panitumumab) And Best Supportive Care Improves Overall Survival Compared To Best Supportive Care In Chemorefractory KRAS And RAS Wild-Type Metastatic Colorectal Cancer Amgen,
Published by
PharmiWeb.com
27 Jan 16 Amgen Announces Webcast of 2015 Fourth Quarter and Full Year Financial Results Amgen,
Published by
PharmiWeb.com
27 Jan 16 FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501 Amgen,
Published by
PharmiWeb.com
24 Jan 16 Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol Amgen,
Published by
PharmiWeb.com
09 Jan 16 Amgen To Present At The 34th Annual J.P. Morgan Healthcare Conference Amgen ,
Published by
PharmiWeb.com
18 Dec 15 Amgen Announces 27 Percent Increase In 2016 First Quarter Dividend Amgen ,
Published by
PharmiWeb.com
01 Dec 15 Amgen's First Biosimilar Biologics License Application For ABP 501 Submitted To U.S. Food And Drug Administration Amgen,
Published by
PharmiWeb.com
23 Nov 15 Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies Amgen ,
Published by
PharmiWeb.com
23 Nov 15 European Commission Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma Amgen ,
Published by
PharmiWeb.com
17 Nov 15 Amgen to Present IMLYGICâ„¢ (Talimogene Laherparepvec) Data at the 2015 International Congress of the Society for Melanoma Research Amgen ,
Published by
PharmiWeb.com
12 Nov 15 Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis Amgen ,
Published by
PharmiWeb.com
11 Nov 15 Amgen And Cytokinetics Announce Late-Breaking Presentation Of COSMIC-HF Trial At AHA Scientific Sessions 2015 Amgen ,
Published by
PharmiWeb.com
11 Nov 15 Amgen Presents Detailed Results From Phase 3 Study Demonstrating Clinical Equivalence Of Biosimilar Candidate ABP 501 With Adalimumab Amgen ,
Published by
PharmiWeb.com
15 Oct 15 Amgen Announces 2015 Fourth Quarter Dividend Amgen ,
Published by
PharmiWeb.com
15 Oct 15 Amgen And LabCentral Announce 2015 Golden Ticket Winners Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen To Acquire Privately-Held Dezima Pharma Amgen ,
Published by
PharmiWeb.com
24 Sep 15 Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215 Amgen ,
Published by
PharmiWeb.com
27 Oct 15 Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec) Amgen ,
Published by
PharmiWeb.com
27 Oct 15 Amgen Foundation Announces New $4 Million Commitment to Bring Hands-On Biotechnology Labs to Secondary School Students Amgen ,
Published by
PharmiWeb.com
27 Oct 15 Amgen Announces Webcast of 2015 Third Quarter Financial Results Amgen ,
Published by
PharmiWeb.com
28 Oct 15 Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure Amgen ,
Published by
PharmiWeb.com
13 Oct 15 New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis Amgen,
Published by
PharmiWeb.com
13 Oct 15 New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide Amgen,
Published by
PharmiWeb.com
03 Nov 15 Amgen To Highlight Cardiovascular Portfolio At American Heart Association Scientific Sessions 2015 Amgen ,
Published by
PharmiWeb.com
07 Nov 15 Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis Amgen,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.